Palladium nanoparticles (Pd NPs) of different shapes
and sizes
have been synthesized by reducing potassium tetrachloropalladinate(II)
by l-ascorbic acid (AA) in an aqueous solution phase in
the presence of an amphiphilic nonionic surfactant poly ethylene glycol
(PEG) via a sonochemical method. Materials have been characterized
by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission
electron microscopy (TEM), energy dispersive X-ray soectrscopy (EDX),
Fourier transform infrared (FTIR), surface-enhanced Raman spectroscopy
(SERS), particle distribution, and zeta potential studies. Truncated
octahedron/fivefold twinned pentagonal rods are formed at room temperature
(RT) (25 °C) while hexagonal/trigonal plates are formed at 65
°C. XRD results show evolution of anisotropically grown, phase-pure,
and well crystalline face-centered cubic Pd NPs at both temperatures.
FTIR and SERS studies revealed adsorption of ascorbic acid (AA) and
PEG at NP’s surface. Particle’s size distribution graph
indicates formation of particles having wide size distribution while
the zeta potential particle surface is negatively charged and stable.
The truncated octahedron/fivefold twinned pentagonal rod-shaped Pd
NPs, formed at RT, while thermally stable and kinetically controlled
hexagonal/trigonal plate-like Pd NPs, evolved at higher temperature
65 °C. The obtained Pd NPs have a high surface area and narrow
pore size distribution. To predict protein reactivity of the Pd cluster,
docking has been done with DNA and lung cancer-effective proteins.
The cytotoxicity of the Pd NPs has been screened on human lung cancer
cells A-549 at 37 °C. The biological adaptability exhibited by
Pd NPs has opened a pathway in biochemical applications.